Adamas Pharmaceuticals Inc Logo Image

Adamas Pharmaceuticals Inc

Most Recent Annual Report

2015 Annual Report and Form 10K

Adamas Pharmaceuticals Inc

Adamas Pharmaceuticals Inc does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Adamas Pharmaceuticals Inc

About Adamas Pharmaceuticals Inc

11-50 Employees
Based in Emeryville, California

Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. The company’s lead product candidate ADS-5102, which completed the Phase II/III clinical trial for the treatment of Parkinson's disease, known as levodopa induced dyskinesia.

Ticker:
ADMS
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drugs - Generic (See More Drugs - Generic Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol